GLP-1s (full name: glucagon-like peptide-1 receptor agonists, or GLP-1 agonists) help the pancreas release insulin, reduce blood sugar, slow the rate of stomach emptying, and increase feelings of fullness, explains Gretchen Zimmermann, RD, a registered dietitian specializing in obesity and vice president of clinical strategy at Vida Health
GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's Mounjaro and Zepbound arent exactly new, but theyve exploded into public consciousness
Shes available in the office to answer questions, administer injections, or provide more info as needed
Heres how it works 1 Online assessment We'll start by learning about you, your health history, and your weight loss goals
A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus erythematosus patients
Why GLP-1s Matter Now Obesity and metabolic disease are at the heart of todays global health crisis